|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA04010417
|
13-epi-10-A4-NeuroP
|
(S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010418
|
ent-10-epi-10-A4-NeuroP
|
(S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010419
|
11-epi-11-A4-NeuroP
|
3-((1R,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010420
|
ent-4-epi-11-A4-NeuroP
|
3-((1R,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010421
|
4,11-diepi-11-A4-NeuroP
|
3-((1S,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010422
|
ent-11-A4-NeuroP
|
3-((1S,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010423
|
11-A4-NeuroP
|
3-((1R,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010424
|
ent-4,11-diepi-11-A4-NeuroP
|
3-((1R,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010425
|
4-epi-11-A4-NeuroP
|
3-((1S,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010426
|
ent-11-epi-11-A4-NeuroP
|
3-((1S,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010427
|
13-epi-13-A4-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010428
|
ent-16-epi-13-A4-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010429
|
13,16-diepi-13-A4-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010430
|
ent-13-A4-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010431
|
13-A4-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010432
|
ent-13,16-diepi-13-A4-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010433
|
16-epi-13-A4-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010434
|
ent-13-epi-13-A4-NeuroP
|
(S,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010435
|
14-epi-14-A4-NeuroP
|
(Z)-6-((1R,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
|
LMFA04010436
|
ent-7-epi-14-A4-NeuroP
|
(Z)-6-((1R,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|